Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Cancer treatment times are being tackled in south Essex in a bid to provide "highest possible quality of care" after alarming new ...

And guys would benefit from paying attention to their skin cancer risk. “The truth is that, in aggregate, men just don’t take ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...